Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Marin, Rebeca
REMODEL-1, NCT05147220 / 2020-005899-36: Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)	Recruiting	3	800	Europe, US, RoW	Remibrutinib, LOU064, Teriflunomide	Novartis Pharmaceuticals, Novartis Pharma AG	Relapsing Multiple Sclerosis	04/26	10/30
MoveS-it, NCT04602390: Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis	Active, not recruiting	1	33	US	ANK-700, Placebo	Anokion SA	Multiple Sclerosis (MS), Relapsing Remitting Multiple Sclerosis	06/24	06/24
PROMISE-GLOB, NCT06421337: BraiN20® Medical Device in Suspected Acute Stroke Patients	Recruiting	N/A	500	Europe	BraiN20(R)	Alicia Martínez Piñeiro	Acute Stroke	12/24	03/25
Crayton, Heidi
REMODEL-1, NCT05147220 / 2020-005899-36: Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)	Recruiting	3	800	Europe, US, RoW	Remibrutinib, LOU064, Teriflunomide	Novartis Pharmaceuticals, Novartis Pharma AG	Relapsing Multiple Sclerosis	04/26	10/30
MoveS-it, NCT04602390: Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis	Active, not recruiting	1	33	US	ANK-700, Placebo	Anokion SA	Multiple Sclerosis (MS), Relapsing Remitting Multiple Sclerosis	06/24	06/24
MASTER-2, NCT03933202: A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS	Active, not recruiting	N/A	295	US	Cladribine Tablets	EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany	Multiple Sclerosis	11/24	11/26
Denson, Danielle
No trials found